Kristian Humer – Biography
Last update: 17 days agoExecutive profile
Kristian was Chief Financial Officer and Chief Business Officer at Viridian Therapeutics, and Managing Director, Healthcare Investment Banking at Citi. Kristian Humer joined Sensei Biotherapeutics in 2025.
Kristian Humer is currentlyChief Financial Officer at 4D Molecular Therapeutics - View - 4D Molecular Therapeutics org chart
Independent Director at Sensei Biotherapeutics - View - Sensei Biotherapeutics org chart
Create your alert
to follow the career of Kristian Humer.
Education
Kristian Humer has a Bachelor of Science in Accounting & Economics from University of Reading and a Master of Business Administration in Finance from Duke University - The Fuqua School of Business.
They have also studied at University of Reading :
Find more alumni from University of Reading
They have also studied at Duke University - The Fuqua School of Business :
Find more alumni from Duke University - The Fuqua School of Business
More about Kristian Humer
Selected links
Do you need to know more about Kristian Humer? More results.
Participate
Social media
- Kristian Humer on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Kristian Humer
The colleagues of Kristian Humer
Company Colleagues
- At 4D Molecular Therapeutics, Kristian Humer has 32 colleagues including David Kirn (President), Susannah Gray (Director)…
- At Sensei Biotherapeutics, Kristian Humer has 19 colleagues including Bob Holmen (Chairman of the Board), Tom Ricks (Director)…
Industry Colleagues
- In the Biotechnology industry, Kristian Humer has 35,756 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Kristian Humer.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Kristian Humer.
